Episode 107 – Drug Pricing and Market Access: “Think of It as a Loop” — Succeeding in an Evolving Policy Landscape
Release Date: 12/16/2025
Episode 128 – Drug Pricing and Market Access: Takeaways from the Medicaid Drug Rebate Program Summit 2026
Connected With Latham
Stakeholders from across the healthcare industry recently convened in Chicago for the Medicaid Drug Rebate Program Summit 2026. In this episode of Connected With Latham, Washington, D.C. partner discusses key takeaways from the conference with , Managing Partner at Magnolia Market Access, and , Founder at Aery Policy & Access Partners. Topics include Most Favored Nation pricing developments, the evolving 340B landscape, Average Sales Price reporting, and the implementation of the Inflation Reduction Act. Also check out our bi-weekly on the website or to receive future editions in...
info_outline
Episode 127 – The Growth Rocketship: Deep Research, Bold Bets, and AI — Inside Maverick Capital’s $15 Billion Portfolios
Connected With Latham
Built on a foundation of deep fundamental research and data-driven insights, Maverick Capital manages over US$15 billion across three distinct pillars: Public Equities, Ventures, and Silicon. Since launching in 2015, Maverick has backed breakout companies in healthcare, biotech, and technology from seed stage through IPO, including SiMa.ai and TensorWave. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Trevor Wiessmann, General Counsel and Chief Compliance Officer at , to explore Trevor’s journey...
info_outline
Episode 126 – Shining a Light on the Sunshine Act and Transparency Requirements: A Primer for Life Sciences Companies
Connected With Latham
The US Physician Payments Sunshine Act requires life sciences companies to publicly report payments, transfers of value, and ownership interests. In the first episode of our Shining a Light on the Sunshine Act and Transparency Requirements series, Washington, D.C. counsel and associate walk listeners through the fundamentals of Sunshine Act compliance, including who is required to report, what types of payments and ownership interests must be reported, and key deadlines and compliance strategies. This podcast is provided as a service of Latham & Watkins LLP. Listening to this...
info_outline
Episode 125 – Drug Pricing and Market Access: The RAPID Pathway
Connected With Latham
The Centers for Medicare & Medicaid Services (CMS) proposed the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway to coordinate FDA device approval and Medicare coverage decisions under one coordinated process from the start — aiming to shrink a historically five-year gap to as few as 60-90 days. In this episode of Connected With Latham, Washington, D.C. partners and , along with associate , break down how RAPID works, how it differs from prior coverage initiatives, and what device manufacturers should consider as the pathway takes shape. Also check out...
info_outline
Episode 124 – The Growth Rocketship: Brave Capital, Defense Tech, Decisive Technologies!
Connected With Latham
San Francisco-based venture capital firm Brave Capital partners with companies from pre-seed through growth equity stages, backing transformative technology startups in sectors ranging from AI to aerospace and energy. The firm backs modern defense disruptors — known as “neoprimes” — that bridge the traditional military-industrial gap, with investments in companies such as . In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Ernestine Fu Mak, Founder and Managing Partner of , to discuss the firm’s...
info_outline
Episode 123 – The Growth Rocketship: Hercules Backs Tech, Life Sciences
Connected With Latham
Hercules Capital provides senior secured loans to high-growth, venture capital-backed companies across technology and life sciences. Since its inception in 2003, Hercules has committed more than US$28 billion to more than 700 companies and works with more than 1,000 leading venture capital and private equity firms. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with , Chief Executive Officer and Chief Investment Officer of Hercules Capital, to discuss Hercules’ investment approach, the role of venture...
info_outline
Episode 122 – Europe Litigation: Mass Actions at a Global Scale
Connected With Latham
Europe has entered the collective redress era. The full implementation of the EU Representative Actions Directive, coupled with a surge in litigation funding, has transformed the ability of claimant groups to coordinate across jurisdictions. Companies now face the prospect of parallel consumer, data privacy, and competition actions that are global in scope — which means the challenge for defendants is not just winning individual cases, but managing consistency of arguments, data strategies, and settlement approaches across multiple fronts. In this episode of Connected With Latham, London...
info_outline
Episode 121 – The Growth Rocketship: Inside Boutique Venture With NewView Capital
Connected With Latham
California-based venture capital and growth firm with more than US$3 billion under management, NewView Capital invests in high-potential technology companies on a primary, secondary, or hybrid basis. Founded in 2018, NewView has emerged as an early leader in the secondary market, taking a boutique, high-conviction approach to backing category-defining companies. Latham has advised NewView on a range of primary, secondary, and hybrid investments across the US and around the world. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies &...
info_outline
Episode 120 – The Growth Rocketship: Modernizing Real Estate With Opendoor
Connected With Latham
Residential real estate platform Opendoor puts homeowners in control by replacing the traditional, passive home-selling process with a streamlined e-commerce system. Founded in 2014, Opendoor has since expanded its reach across the lower 48 states, building out a partner network and tackling the complex ecosystem of utilities, title, escrow, and mortgage that surrounds every home sale. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Christy Schwartz, Opendoor’s Chief Financial Officer, and Rishi...
info_outline
Episode 119 – The Growth Rocketship: How Rakuten Capital Masters Diplomatic Capitalism
Connected With Latham
The corporate venture capital arm of Rakuten Group, Rakuten Capital invests in innovative startups across fintech, AI, and other high-growth sectors. Since its founding in 2014, Rakuten Capital has invested in companies like Lyft, Pinterest, Careem, and Upstart, establishing itself as a distinctive force in corporate venture investing. In this episode of Connected With Latham, , Global Vice Chair of Latham’s Emerging Companies & Growth Practice, sits down with Saemin Ahn, Managing Partner of Rakuten Capital and Executive Officer of Rakuten Group, to discuss Rakuten Capital’s...
info_outlineThe pharmaceutical industry has seen major legal and policy changes in recent years, from the Inflation Reduction Act to the Trump administration’s aggressive pricing policies. In this episode of Connected With Latham, Mike Domanico, a pharmaceutical industry veteran with experience in Big 4, brand drugs, biosimilars, and generics, and most recently Vice President of Revenue Finance, joins Washington, D.C. partner Chris Schott and associate Danny Machado to discuss how organizations can best respond to the changing environment. As Mike explains, think of meeting the challenge as a loop that connects the business, compliance, and legal in a cross-functional collaboration. Also check out our bi-weekly Drug Pricing Digest on the website or subscribe to receive future editions in your inbox.
This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York’s Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200